mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.4 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.14 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
-0.097 |
0.4 |